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Nanoparticles-cell	association	predicted	by	protein	corona	
fingerprints	
S.	Palchetti,a,b	L.	Digiacomo,a,c	D.	Pozzi,a,b	G.	Peruzzi,d	E.	Micarelli,e	M.	Mahmoudif,g*	and	G.	
Caraccioloa,b*	
In	a	physiological	environment	(e.g.,	blood	and	interstitial	fluids)	nanoparticles	(NPs)	will	bind	proteins	shaping	a	“protein	
corona”	 layer.	 The	 long-lived	 protein	 layer	 tightly	 bound	 to	 the	NP	 surface	 is	 referred	 to	 as	 the	 hard	 corona	 (HC)	 and	
encodes	information	that	controls	NP	bioactivity	(e.g.	cellular	association,	cellular	signaling	pathways,	biodistribution,	and	
toxicity).	Decrypting	this	complex	code	has	become	a	priority	to	predict	the	NP	biological	outcomes.	Here,	we	use	a	library	
of	 16	 lipid	NPs	 of	 various	 size	 (Ø	 ≈	 100-250	 nm)	 and	 surface	 chemistry	 (unmodified	 and	 PEGylated)	 to	 investigate	 the	
relationships	 between	NP	physicochemical	 properties	 (nanoparticle	 size,	 aggregation	 state	 and	 surface	 charge),	 protein	
corona	fingerprints	(PCFs),	and	NP-cell	association.	We	found	out	that	none	of	the	NPs’	physicochemical	properties	alone	
was	exclusively	able	to	account	for	association	with	human	cervical	cancer	cell	line	(HeLa).	For	the	entire	library	of	NPs,	a	
total	of	436	distinct	serum	proteins	were	detected.	We	developed	a	predictive-validation	modeling	that	provides	a	means	
of	 assessing	 the	 relative	 significance	 of	 the	 identified	 corona	 proteins.	 Interestingly,	 a	minor	 fraction	 of	 the	HC,	which	
consists	of	only	8	PCFs	were	identified	as	main	promoters	of	NP	association	with	HeLa	cells.	Remarkably,	identified	PCFs	
have	several	receptors	with	high	level	of	expression	on	the	plasma	membrane	of	HeLa	cells.		
Introduction	
When	 suspended	 in	 physiological	 milieu	 (e.g.,	 blood	 and	
interstitial	 fluids)	 nanoparticles	 (NPs)	 will	 bind	 proteins	 that	
shape	a	 “protein	 corona”	 layer	on	 the	NP	external	 surface.1-5	
This	corona,	as	described	by	 the	 types	of	 serum	proteins	and	
their	 abundance	on	 the	NP	 surface,	 depends	on	both	 the	NP	
physicochemical	properties6,	7	and	the	blood	protein	source.3,	8,	
9	Recent	developments	have	 revealed	 that	corona	decoration	
is	 largely	 affected	 by	 the	 type	 of	 human	 patient	 from	which	
the	 plasma	 is	 obtained.9,	 10	 Temperature11,	 12	 and	 exposure	
time13,	14	have	been	also	identified	as	strategic	factors	shaping	
both	 the	 NP	 physicochemical	 properties	 and	 the	 NP-corona.	
The	 corona	 is	 composed	 by	 an	 outer	 short-lived	 layer	 in	
dynamical	equilibrium	with	the	surrounding	environment	(the	
“soft	 corona”)	 and	 a	 long-lived	 layer	 tightly	 bound	 to	 the	NP	
surface,	 referred	 to	 as	 the	 hard	 corona	 (HC).15	 Being	 the	 NP	
interface	seen	by	cells,	the	HC	is	thought	to	give	a	new	identity	
to	the	NP	by	encoding	information	that	controls	NP	bioactivity	
(e.g.	cellular	association).1,	 15-17	Thus,	 interpreting	such	cryptic	
code	 has	 become	 a	 priority	 to	 predict	 the	 NP	 biological	
outcomes.	 To	 this	 end,	 a	 number	 of	 quantitative	 structure–
activity	 relationships	 (QSARs)	 have	 been	 successfully	
developed.18	 Physicochemical	 properties	 used	 as	 descriptors	
are	 those	 that	 characterize	 the	 biological	 identity	 of	 NPs	
suspended	 in	 a	 biological	 fluid,	 i.e.	 their	 size,	 zeta-potential,	
and	aggregation	state.2,	 18	 In	addition,	 the	relative	abundance	
of	 the	 identified	proteins	adsorbed	on	 the	NP	surface	 is	used	
as	a	“fingerprint”	to	characterize	the	HCs.		
For	 some	 classes	 of	 inorganic	 nanomaterials	 (e.g.	 gold	 NPs)	
correlations	 of	 HC	 fingerprints	 with	 cell	 association	 were	
demonstrated.2,	18,	19	Currently,	organic	nanomaterials	such	as	
liposomes	 and	 polymers	 are	 tested	 for	 a	 wide	 range	 of	
applications,	 ranging	 from	 nanobiomedicine	 to	 consumer	
products.	In	any	cases,	clear-cut	explanation	of	the	role	played	
by	their	HC	in	mediating	cell	association	is	still	missing.		
In	this	work,	we	employed	a	compositionally	diverse	library	of	
16	negatively	or	positively	charged	lipid	NPs	of	various	size	(Ø	
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Table	 1.	Nanoparticle	 characterization.	 The	 average	 size	 of	 16	 nanoparticles	with	 different	 surface	 chemistry	was	 determined	 in	 buffer	 by	 DLS.	 Plasma	measurements	were	
performed	1	hour	post-exposure	to	human	plasma	(HP),	followed	by	plasma	separation	and	subsequent	washing	as	described	in	Materials	and	Methods	section.	Zeta-potential	of	
the	 different	 nanoparticles	 in	 buffer	 and	 after	 1	 hour	 post-exposure	 to	 HP.	 Values	 are	mean	 ±	 s.d.	 from	 three	 independent	 experiments.	Micrograms	 of	 proteins	 bound	 to	
liposomes	after	1	hour	incubation	with	HP.	
	
	
	
	
	
	
	
	
	
	
	
	
	
≈	 100-250	 nm)	 and	 surface	 chemistry	 (unmodified,	
PEGylated)	 and	 we	 let	 them	 interact	 with	 human	 plasma	
(HP).	 Thus,	 the	 selected	 model	 systems	 are	 relevant	 for	
nanobiomedicine	 and	 nanotoxicology.	 NP	 coronas	 were	
highly	 complex	 in	 composition,	 each	 of	 them	 being	
composed	 of	 about	 200	 different	 proteins.	 Here	we	 show	
that	 a	 minor	 fraction	 of	 the	 HC,	 which	 consists	 of	 only	 8	
proteins,	 controls	 cell	 association	 of	 selected	 NPs	 with	
human	cervical	cancer	cell	 line	(HeLa)	cells.	These	cells	are	
widely	 used	 as	 a	 model	 to	 study	 fundamental	 NP-cell	
interactions.	
Results	and	Discussion	
Particles	were	incubated	with	undiluted	HP	for	1	hour	at	37	
°C,	 separated	 from	 plasma	 components	 by	 centrifugation,	
washed	and	resuspended	in	protein-free	medium.	It	should	
be	noted	that	plasma	is	a	better	model	than	serum	for	the	
in	 vivo	 human	 environment,	 since	 not	 only	 key	 blood	
coagulation	factors	are	absent	in	serum	but	also	the	plasma	
is	the	real	protein	source	that	NPs	may	“see”	in	vivo.20	HC-
coated	NPs	were	thoroughly	characterized	by	dynamic	light	
scattering	(DLS)	and	zeta-potential	measurements	(Table	1).	
Due	 to	 the	 formation	 of	 protein	 corona	 layer,	 the	 HC-
coated	NPs	were	 bigger	 in	 size	 than	 bare	NPs.	 Increase	 in	
size	 ranged	 between	 10	 and	 120	 nm	 and,	 for	 13	 of	 16	
formulations,	 was	 not	 compatible	 with	 particle	
aggregation21,	22	(Figure	S1	in	the	Electronic	Supplementary	
Information,	 ESI).	 For	 monodisperse	 HC-coated	 NPs	 the	
change	 in	 size	 after	 plasma	 exposure	 changes	
monotonously	 with	 hydrodynamic	 diameter	 of	 NPs	 after	
incubation	with	human	plasma	(Figure	S1	in	the	ESI).		
HC-coated	NPs,	 irrespective	of	 the	bare	particles’	negative	
or	 positive	 surface	 functionalization,	 display	 an	 overall	
negative	 charge	 (Table	 1).	 After	 plasma	 exposure	 the	
variation	 in	 zeta-potential	 is	 a	 linear	 function	 of	 the	 zeta-
potential	 after	 synthesis	 (Figure	 S1	 in	 the	 ESI).	 Plasma	
incubation	 resulted	 in	 a	 “normalization”	 of	 the	 zeta-
potential	 to	 an	 average	 value	 of	 about	 -21	 ±	 5	 mV	
independently	of	 the	pristine	surface	charge.	Most	plasma	
proteins	carry	a	net	negative	charge	at	physiological	pH	7.4.	
Upon	adsorption,	the	anionic	plasma	proteins	impart	a	net	
negative	charge	to	the	NP.	It	was	suggested	that	negatively	
charged	 particles	 attract	 primarily	 positively	 charged	
proteins	 and	 vice	 versa.	 However,	 the	 observed	 behavior,	
which	was	previously	 detected	 for	metal	NPs	with	 varying	
physicochemical	properties,2	indicates	that	the	main	driving	
force	 in	 the	 protein-NP	 interaction	 is	 not	 merely	
electrostatic.		
There	 is	 a	 current	 debate	 as	 to	 whether	 NP’s	
physicochemical	 features	 such	 as	 size	 and	 surface	 charge	
affect	 the	NP-cell	 association.	Previous	 studies	proposed	a	
size-dependent	 mechanism	 of	 NP-cell	 association.23	 Other	
studies	 reported	 that	 the	 surface	 properties	 of	 different	
NPs	were	 as	 relevant	 as	 particle	 size	 for	 cellular	 uptake.24	
HC-coated	NPs	were	highly	heterogeneous	both	in	size	and	
zeta-potential	(Table	1).	Thus,	the	chosen	library	of	NPs	was	
particularly	 attractive	 to	 investigate	 the	 role	 of	 these	
factors	 on	 the	 NP-cell	 association.	 When	 HeLa	 cells	 were	
exposed	 to	 HC-coated	 NPs,	 no	 sign	 of	 cytotoxicity	 was	
detected	 using	 	 MTT	 approach	 (Table	 S1	 in	 the	 ESI).	 Cell	
association	 of	 fluorescently	 labeled	 HC-coated	 NPs,	 which	
includes	internalization	of	the	NPs	and	adhesion	to	the	cell	
membrane,18	 was	 evaluated	 by	 flow	 cytometry.	 Notably,	
significant	 differences	 in	 cell	 adhesion	 were	 observed	
between	 formulations	with	percentage	of	 fluorescent	 cells	
varying	between	≈	1	and	100%	(Table	S1	in	the	ESI),	which	
underlines	 the	 necessity	 to	 dissect	molecular	mechanisms	
responsible	 for	NP-cell	association.	NP-cell	association	was	
insensitive	 to	 size,	 zeta-potential,	 and	 aggregation	 state	
(Figure	 S2	 in	 the	 ESI).	 Collectively,	 our	 analyses	
demonstrate	 that	 none	 of	 the	 NPs’	
physicochemicalproperties	 alone	 was	 able	 exclusively	 to	
account	 for	association	with	HeLa	cells.	On	 the	other	 side,	
increasing	
Surface chemistry Protein Assay (ug/ul)
In Buffer Plasma In Buffer Plasma Plasma
NP1 Cationic, plain 112 ± 11 (0.17) 228 ± 4 (0.23) 48.5 ± 0.9 -17.9 ± 0.7 9.7 ± 1.1
NP2 Cationic, plain 135 ± 8 (0.14) 259 ± 21 (0.12) 30.1 ± 3.4 -19.3 ± 1.8 5.06 ± 0.45
NP3 Cationic, plain 128 ± 17 (0.11) 150 ± 6 (0.15) 47.4 ± 0.9 -23.0 ± 1.1 10.55 ± 0.89
NP4 Cationic, plain 131 ± 7 (0.10) 182 ± 13 (0.16) 26.1 ± 2.9 -25.5 ± 1.4 5.51 ± 0.54
NP5 Cationic, plain 157 ± 10 (0.17) 211 ± 14 (0.23) 58.2 ± 4.3 -28.5 ± 2.3 6.70 ± 0.62
NP6 Cationic, plain 108 ± 4 (0.14) 216 ± 2 (0.22) 34.5 ± 5.5 -17.9 ± 2.3 4.02 ± 0.43
NP7 Cationic, plain 125 ± 10 (0.18) 207 ± 12 (0.21) 46.2 ± 2.2 -20.4 ± 4.5 5.47 ± 0.56
NP8 Cationic, plain 254.6 ± 22.9 (0.12) 329 ± 12 (0.15) 33.1 ± 2.4 -15.4 ± 1.2 4.36 ± 0.28
NP9 Cationic, plain 193.4 ± 15.2 (0.13) 236 ± 18 (0.19) 42.1 ± 1.2 -19.3 ± 1.4 3.93 ± 0.27
NP10 Zwitterionic, plain 191 ± 23 (0.11) 301 ± 18 (0.15) -8.4 ± 1.9 -22.1 ± 2.3 2.94 ± 0.32 
NP11 Anionic, plain 136 ± 1 (0.10) 152 ± 12 (0.15) -26.6 ± 0.2 -18.2 ± 0.8 8.50 ± 1.09
NP12 Anionic, plain 126 ± 23 (0.11) 171 ± 11 (0.13) -14.2 ±1.1 -28.6 ± 1.4 4.06 ± 0.51
NP13 Cationic, plain 144 ± 4 (0.09) 178 ± 6 (0.14) 30.2 ± 2.9 -29.3 ± 3.5 4.91 ± 0.64
NP14 Cationic, PEGylated 114 ± 1 (0.08) 137 ± 6 (0.16) 18.1 ± 3.3 -13.9 ± 0.6 2.70 ± 0.21
NP15 Cationic, PEGylated 123 ± 6 (0.12) 169 ± 6 (0.17) 17.9 ± 1.2 -24.5 ± 1.2 1.50 ± 0.03
NP16 Cationic, PEGylated 103.2 ± 9.7 (0.09) 115 ± 1 (0.13) 9.9 ± 2.2 -13.2 ± 0.9 1.10 ± 0.12
DLS hydrodynamic diameter ± s.d. (nm) (PDI) Zeta potential ± s.d. (mV)
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Figure	1.	Proteins	identified	in	the	nanoparticles’	coronas	by	quantitative	LC-MS.	The	relative	protein	abundance	of	proteins	is	shown.	The	concentration	of	proteins	involved	in	
complement	 activation,	 coagulation,	 acute	 phase	 and	 tissue	 leakage	 were	 particularly	 strongly	 affected	 by	 nanoparticle	 physicochemical	 properties.	 Complement	 activation	
proteins	 bound	 preferentially	 to	 NP9,	 NP10,	 NP15	 and	 NP	 16.	 Lipoproteins	 bound	 preferentially	 to	 NP2	 and	 NP4,	 whereas	 enhanced	 binding	 of	 tissue	 leakage	 proteins	was	
observed	for	NP2.	Although	immunoglobulins	are	present	in	high	amounts	in	the	plasma,	these	proteins	displayed	distinct	binding	to	all	nanoparticles	with	RPA	ranging	from	5%	
(NP)	to	30%	(NP).	Detailed	values	for	all	individual	proteins	are	available	in	Tables	S3	and	S4	in	the	ESI.	
evidence	has	shown	that	 the	protein	corona	regulates	NP-
cell	 recognition,	 and	 hence	 plays	 important	 roles	 in	
modulating	NP’s	bioactivity.9,	13	For	example,	the	adsorption	
of	 proteins	 on	 NPs	 has	 been	 shown	 to	 impact	 on	 the	
specificity	 of	NPs	 to	 targeted	 cells,	 resulting	 in	 the	 loss	 or	
reduction	 of	 the	 targeting	 capability	 of	 surface	
functionalized	 NPs.25,	 26	 On	 the	 flip	 side,	 a	 long-standing	
corona	 with	 receptor-binding	 sites	 could	 stimulate	
association	 with	 the	 cell	 hence	 triggering	 particle	
endocytosis	 and	 intracellular	 cargo	 delivery.	 Thus,	
prediction	of	the	biological	 impact	of	the	adsorbed	protein	
corona	requires	a	full	characterization	of	its	composition.		
The	 HC	 of	 the	 entire	 collection	 of	 NP	 was	 quantitatively	
characterized	by	nano	liquid	chromatography	tandem	mass	
spectrometry	 (nanoLC-MS/MS).27-30	 The	 accuracy	 and	
reproducibility	 of	 the	nanoLC	MS/MS	 characterization	was	
established	 using	 3	 independent	 experimental	 replicates	
and	 3	 technical	 replicates	 for	 each	 of	 the	 experimental	
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ones.	Over	the	entire	 library,	N=436	distinct	proteins	were	
identified	 and	 quantified.	 For	 each	 NP	 formulation,	 the	
total	 number	 of	 identified	 proteins	 and	 their	 relative	
abundance	 did	 depend	 on	 both	 formulation	 and	 surface	
ligand	 chemistry	 (Table	 S2	 in	 the	 ESI).	 On	 average,	 each	
formulation	 adsorbed	 195	 ±	 33	 distinct	 plasma	 proteins.	
Tables	 S3-S19	 in	 the	 ESI	 lists	 the	 most-abundant	 proteins	
for	each	NP.	Our	data	verifies	 that	 the	 relative	abundance	
of	 proteins	 in	 the	 corona	 of	 lipid	 NP	 does	 not,	 generally,	
reproduce	their	 relative	abundance	 in	plasma	because	 low	
abundance	 proteins	 are	 enriched	 on	 the	 NP	 surface.	
Previous	investigations	have	shown	that	the	protein	corona	
of	inorganic	NPs	appears	to	follow	a	general	structure,	with	
the	top	3	most	abundant	proteins	representing	on	average	
roughly	55%.2	In	this	regard,	the	protein	corona	of	lipid	NPs	
seems	 to	 be	more	 heterogeneous	 in	 composition	with	 25	
hits	representing	on	average	about	60%.		
To	 facilitate	 their	 rational	 identification,	 proteins	 were	
categorized	 bioinformatically	 according	 to	 biological	
processes	 of	 the	 blood	 system	 (Figure	 1).	 The	 relative	
protein	 abundance	 (RPA)	 of	 biologically	 relevant	 proteins	
such	 as,	 proteins	 involved	 in	 complement	 activation,	
coagulation,	 immune	 response,	 acute	 phase	 and	 tissue	
leakage	were	particularly	affected	by	NP’s	characteristics.	In	
particular,	 while	 immunoglobulins	 are	 present	 in	 high	
concentrations	in	the	plasma,	these	proteins	exhibited	only	
moderate	 adsorption	 to	 most	 NP	 formulations.	 A	
functionally	 diverse	 group	 of	 plasma	 proteins	 highly	
enriched	in	the	coronas	of	lipid	NPs	are	the	apolipoproteins.	
Apolipoproteins	were	 enriched	 significantly	 in	 the	 coronas	
of	 NP1-4	 and	 are	 likely	 to	 trigger	 NP-induced	 biological	
responses.	 Particularly,	 APOA-I,	 APOB,	 and	 APOE	 enable	
targeted	 delivery	 of	 drugs	 to	 the	 lung	 tumors,31	 enhance	
the	 uptake	 of	 lipid	 NP	 by	 hepatocytes32	 and	 help	 NPs	
towards	crossing	the	blood	brain	barrier.33,	34		
Given	 the	 involvement	 of	 corona	 proteins	 in	 many	
biological	 processes,	 their	 identification	 and	 quantification	
is	a	fundamental	step	towards	prediction	of	NP	behavior	in	
vivo.	In	this	regard,	protein	abundance	is	not	the	only	factor	
to	 consider.	 Indeed,	 highly	 enriched	 proteins	 might	 be	
unfolded35	or	their	functional	motifs	buried	inside.28	On	the	
other	 side,	 poorly	 enriched	 but	 exposed	 proteins	 could	
favorably	 interact	 with	 receptors	 of	 target	 cells.	 These	
arguments	highlight	how	prediction	of	NP-cell	adhesion	will	
require	more	than	just	the	knowledge	of	the	protein	corona	
composition,	but	accurate	mapping	protein-binding	sites	on	
the	NP	 corona.36	Many	 receptors	 exist	 on	 cell	membranes	
such	 as	 folate	 and	 transferrin	 receptors,	 growth	 factor	
receptors	 and	 integrins.	 Thus,	 if	 multiple	 epitopes	 of	
different	 corona	 proteins	 are	 exposed,	 they	 could	 be	
recognized	by	different	 cell	 receptors.	As	a	matter	of	 fact,	
simultaneous	 binding	 of	 multiple	 ligands	 to	 multiple	 cell	
receptors	naturally	occurs	 in	many	biological	 systems.	 The	
multivalent	 effect,	 i.e.	 the	 multivalent	 binding	 between	
multiple	 ligands	 and	multiple	 receptors	 is	 critical	 to	many	
cellular	 processes	 and	 can	 confer	 several	 advantages	 such	
as	 higher	 biological	 recognition,	 improved	 and	 tight	
binding.37	An	example	of	polyvalent	interactions	relevant	to	
human	biology	 is	given	by	the	 influenza	virus	that	binds	to	
cells	by	multiple	 interactions.38	Of	note,	a	growing	number	
of	viruses	have	been	found	to	use	many	types	of	receptors	
for	the	attachment	to	target	cells	and	the	same	mechanism	
is	still	valid	for	bacteria-cell	interactions.38		
Deciphering	 which	 corona	 proteins	 play	 a	 role	 on	 NP	
cellular	 association	 is	 a	 challenging	 question	 since	
mastering	 the	 NP-protein	 corona	 itself	 could	 be	 a	 novel	
means	to	target	diseases	instead	of	chemical	grafting.	Cells	
could	 therefore	 interact	 with	 protein-NP	 complexes	 via	 a	
multitude	 of	 different	 receptors,	 which	 have	 saturable	
binding	 sites.	 In	 this	 regard,	 association	 of	 HC-coated	NPs	
with	target	cells	would	resemble	that	of	ligands/antibodies-
linked	 NPs	 targeting	 several	 membrane	 receptors	
simultaneously.	When	 ligand-grafted	NPs	are	administered	
to	 cells,	 cellular	 association	 shows	 a	 typical	 saturable	
dependence	 on	 the	 NP	 concentration.	 According	 to	 all	
these	 evidences	 was	 the	 idea	 to	 identify	 specific	 protein	
corona	 fingerprints	 that	 let	 NP-cell	 association	 exhibit	
saturable	 dependence	 on	 their	 abundance.	 To	 determine	
which	protein	fingerprints	promote	cell	association,	a	two-
step	procedures	was	used.	In	the	first	step,	list	of	predictors	
was	created	(Table	S20	in	the	ESI).	The	list	comprised	n=14	
corona	 proteins	 that	 are	 usually	 categorized	 as	 being	
positively	 correlated	with	NP	cell	 association18	 22,	 39,	 40	 and	
represented	on	average	about	60%	of	the	PC	(Table	S20	in	
the	 ESI).	 Then,	 we	 developed	 a	 m×n	 Pij	 matrix,	 that	
identifies	 the	 relative	 amount	 of	 the	 protein	 j	 within	 the	
corona	of	the	i-th	formulation.	The	cellular	association	Ai	of	
the	i-th	formulation	can	be	regarded	as	a	function	of	some	
specific	 contributions	 among	 the	 n	 measured	 protein	
abundances,	i.e.		
	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 (1)	
	
Where	Γ	 indicates	 the	 set	of	 indexes	 corresponding	 to	 the	
proteins	 that	 are	 included	 in	 the	 list	 of	 predictors.	 In	 the	
first	 step	 (hereafter	 named	 ‘step	 I’),	 the	 aim	 was	 to	
determine	 the	 k	 elements	 in	 Γ	 (k≤n),	 which	 best	
approximate	 A	 to	 a	 saturation	 function	 f.	 Since	 the	
association	 is	 defined	 as	 percentage	 of	 fluorescent	 cells,	 f	
must	have	values	within	the	range	[0,100]		
	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 (2)	
	
The	 best	 ensemble	 Γ	 was	 evaluated	 by	 means	 of	 least	
square	 method,	 i.e.	 by	 fitting	 A	 through	 f,	 where	 the	
independent	variable	 is	represented	by	the	partial	sums	of	
the	 protein	 abundances.	 Thus,	 for	 each	 k-value,	 	 	 	 fitting	
curves	were	obtained,	each	of	them	for	any	possible	sum	of	
k	terms	belonging	to	the	list	of	n	descriptors.		
Among	the																	combinations,	prediction	accuracy	was		
	
evaluated	in	terms	of	fitting	determination	coefficient	R2.		
!! = ! !!"!∈! 	
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Figure	2.	 (A)	Prediction	accuracy	 (R2)	 as	a	 function	of	 increasing	number	of	descriptors	 (k).	 In	Step	 I,	n=14	descriptors	are	 chosen	among	 the	N=436	proteins	 identified	 in	 the	
nanoparticle-coronas.	For	each	k-value,	all	their							possible	combinations	are	explored.	In	step	I,	the	highest	accuracy	was	achieved	with	kI=6	(blue	square,	R
2=0.920).	In	Step	II	a	
one-at-a-time	 sensitivity	 analysis	was	 performed	with	 the	 aim	of	 exploring	 the	 involvement	 of	 the	 (N-n)	 corona	 proteins	 that	were	 excluded	 in	 Step	 I.	 Step	 II	 resulted	 in	 the	
inclusion	of	two	more	PCFs.	Red	circle	identifies	the	“turning-point”	where	the	prediction	accuracy	was	maximum	(R2=0.972).	This	was	achieved	with	a	final	set	of	kII=8	proteins.	
(B).	Cellular	association	of	NPs	as	a	function	of	the	total	protein	abundance	of	the	8	PCFs	identified	in	the	two-step	procedure	described	in	panel	A.	(C)	Ranking	coefficient	of	the	8	
PCFs.		
	
As	shown	in	the	panel	A	of	Figure	2,	the	prediction	accuracy	
R2	was	highly	dependent	on	k	and	exhibits	a	“turning-point”	
at	 kI=6.	 Hence,	 step	 I	 of	 the	 procedure	 allowed	 us	 to	
determine	a	set	of	6	elements	(Vitronectin,	APOA1,	APOA2,	
APOB,	 APOC2,	 Integrin	 beta3),	 which	 promote	 NP	
association	to	HeLa	cells.	The	extremely	high	computational	
cost	 of	 step	 I	 did	 not	 allow	 us	 to	 include	 all	 the	 detected	
proteins	 (i.e.	N=436)	within	 the	 starting	 set	of	descriptors.	
Step	 II	was	 devoted	 to	 overcoming	 this	 limit.	 To	 this	 end,	
we	 adopted	 a	 one-at-a-time	 sensitivity	 analysis	 aimed	 at	
exploring	 the	 involvement	 of	 all	 the	 (N-n)	 proteins	 that	
were	 excluded	 in	 Step	 I	 (a	 detailed	 description	 of	 the	
procedure	 is	 given	 in	 Figure	 S3	panel	A	 in	 the	ESI).	 Step	 II	
resulted	in	the	boost	of	prediction	accuracy	(Figure	2,	panel	
A)	 by	 inclusion	 of	 two	 more	 PCFs.	 The	 final	 set	 of	 kII=8	
proteins	ensured	a	high	prediction	accuracy	(Figure	2,	panel	
B).	 It	 was	 noteworthy	 that,	 of	 the	 entire	 pool	 of	 possible	
descriptors	 (N=436	 proteins),	 a	 very	 small	 set	 of	 8	 PCFs	
(Vitronectin,	APOA1,	APOA2,	APOB,	APOC2,	 Ig	heavy	chain	
V-III	 region	 BRO,	 Vitamin	 K-dependent	 protein,	 Integrin	
beta3)	demonstrated	the	greatest	impact	on	the	correlation	
of	NP	cell	association.	Notably,	the	same	proteins	were	also	
identified	 in	 previous	 works	 as	 being	 highly	 relevant	 to	
correlating	NP-cell	association.		
Further	implication	of	the	procedure	was	the	production	of	
a	 ranking	 coefficient,	 l,	 by	 which	 all	 the	 corona	 proteins	
were	 classified	 in	 their	 ability	 to	 promote	 cell	 association	
(Figure	 2	 panel	 C	 and	 Figure	 S3	 panel	 B	 in	 the	 ESI).	
Vitronectin	was	the	most	relevant	PCF	followed	by	APOA1,	
APOA2,	 APOB	 and	 APOC2.	 The	 most	 relevant	 protein	
seemed	 to	 be	 Vitronectin	 is	 a	 glycoprotein	 and,	 together	
with	fibronectin,	 is	one	of	the	major	cell	adhesion	proteins	
in	plasma.	Vitronectin	interact	with	glycosaminoglycans	and	
proteoglycans	and	is	recognized	by	certain	members	of	the	
integrin	 family	 such	 as	 avb3.	 Vitronectin	 contains	 the	 Arg-
Gly-Asp	(RGD)	motif	 in	the	Somatomedin	B	domain	(20−63	
region)	 that	 is	 specifically	 recognized	 by	 ανβ3	 integrins,	
which	 are	 overexpressed	 on	 many	 solid	 tumors	 and	 in	
tumor	 neovasculature.	 APOA1,	 APOA2	 interact	 selectively	
and	 non-covalently	 with	 the	 apolipoprotein	 receptor.41	
APOB	has	been	reported	to	act	as	a	ligand	for	LDL	receptors	
in	 various	 cells.	APOC2	 is	 secreted	 in	 plasma	where	 it	 is	 a	
component	 of	 very	 low-density	 lipoproteins	 (VLDL)	 and	
chylomicrons.	 APOC2	 is	 an	 activator	 of	 lipoprotein	 lipase	
(LPL)	 and	 its	 structure	 is	 predicted	 to	 contain	 3	 helical	
regions,	which	 are	 thought	 to	 be	 involved	 in	 phospholipid	
binding.	Interestingly,	this	finding	seems	to	suggest	that	not	
only	cell	receptors,	but	also	lipids	of	the	plasma	membrane,	
could	 be	 involved	 in	 the	 corona-mediated	 endocytosis	 of	
NPs.		
This	 aspect	 deserves	 further	 consideration	 and	 is	 being	
currently	 investigated	in	our	 laboratory.	On	the	other	side,	
the	 ranking	coefficients	of	 Ig	heavy	chain	V-III	 region	BRO,	
Vitamin	K-dependent	protein	and	Integrin	beta3	were	lower	
suggesting	 a	 minor	 role	 of	 those	 proteins	 on	 NP-cell	
association.	 To	 rationalize	 the	 identification	 of	 the	 PCFs	
potentially	associated	with	the	protein	corona	components,	
a	 bioinformatics	 analysis	 of	 protein	 cell	 receptors	 was	
performed	 (detailed	 information	 can	 be	 found	 in	 the	
Materials	 and	Methods	 section).	 In	 brief,	 for	 each	 protein	
belonging	 to	 the	 selected	 set	 of	 PCFs,	 we	 determined	 its	
interaction	 partners	 (and	 levels	 of	 expression)	 on	 the	
external	 side	 of	 the	 plasma	 membrane	 of	 Hela	 cells.	
Remarkably,	 we	 found	 out	 that	 our	 two-step	 procedure	
resulted	in	the	identification	of	PCFs	with	several	receptors	
on	 the	 plasma	membrane	 of	 HeLa	 cells	 (Table	 S21	 in	 the	
ESI).	 For	 each	 PCF,	 at	 least	 one	 cell	 receptor	 exhibited	 a	
high	 level	 of	 expression	 as	 quantified	 by	
the		GENEVESTIGATOR	tool.	
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Materials	and	Methods	
Nanoparticle	preparation	
Cationic	 lipids	 1,2-dioleoyl-3-trimethylammonium-propane	
(DOTAP)	 and	 (3β-[N-(Nʹ,Nʹ-dimethylaminoethane)-
carbamoyl])-cholesterol	 (DC-Chol),	 zwitterionic	 lipids	
dioleoylphosphocholine	 (DOPC),	
dioleoylphosphatidylethanolamine	 (DOPE),	 DOPE-
polyethyleneglycol	 (PEG)-1K,	 DOPE-PEG-2K,	 DOPE-PEG-5K,	
1,2-distearoyl-sn-glycero-3-phosphocholine	 (DSPC),	 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine	 (DPPC)	 and	 1,2-
diarachidoyl-sn-glycero-3-phosphocholine	 (20:0	 PC)	 and	
anionic	 lipids	 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol)	 (DOPG)	 and	 1,2-dioleoyl-sn-glycero-3-phosphate	
(DOPA)	were	purchased	from	Avanti	Polar	Lipids	(Alabaster,	
AL).	Sphingosine,	Cholesterol	(Chol)	and	DOPE	labeled	with	
7-nitrobenzofurazan	 (NBD)	 were	 purchased	 from	 Sigma-
Aldrich	 (St.	 Louis,	 MO,	 USA).	 All	 lipids	 were	 used	 without	
further	 refinement.	 Sixteen	 nanoparticle	 formulations	
(indicated	 as	 NP1-NP16)	 were	 prepared	 at	 desired	 molar	
ratios.	 Each	 lipid	 was	 dissolved	 in	 chloroform	 and	 the	
solvent	 was	 evaporated	 under	 a	 vacuum	 for	 at	 least	 24	
hours.	 Lipid	 films	 were	 hydrated	 to	 obtain	 a	 final	 lipid	
concentration	 of	 1	 mg/mL	 with	 ultrapure	 water	 for	 size,	
zeta-potential,	 cytotoxicity	 and	 flow	 cytometry	
experiments.	 For	 proteomics	 experiments	 lipid	 films	 were	
hydrated	with	a	dissolving	buffer	(Tris–HCl,	pH	7.4,	10	mmol	
L−1;	NaCl,	150	mmol	L−1;	EDTA,	1	mmol	L−1)	and	stored	at	4	
°C.	 The	 obtained	 liposome	 solutions	 were	 extruded	 20	
times	through	a	0.1µm	polycarbonate	carbonate	filter	with	
the	Avanti	Mini-Extruder	(Avanti	Polar	Lipids,	Alabaster,	AL).	
Size	and	zeta-potential	
Dynamic	 light	 scattering	 experiments	 and	 laser	 Doppler	
electrophoresis	were	carried	out	to	measure	nanoparticles'	
size	 and	 zeta-potential.	 All	 the	measurements	were	made	
at	 25°C	 on	 a	 Zetasizer	 Nano	 ZS90	 spectrometer	 (Malvern,	
U.K.)	 equipped	 with	 a	 5	 mW	 HeNe	 laser	 (wavelength	 λ	 =	
632.8	nm)	and	a	non	invasive	back-scattering	optical	setup	
(NIBS).	 For	 each	 sample,	 the	 detected	 intensity	 was	
processed	 by	 a	 digital	 logarithmic	 correlator,	 which	
computes	a	normalized	intensity	autocorrelation	functions.	
Then,	 the	 distribution	 of	 the	 diffusion	 coefficient	 D	 was	
obtained	 by	 using	 the	 CONTIN	 method.42	 Finally,	 D	 was	
converted	 into	 an	 effective	 hydrodynamic	 radius	 RH	
through	 the	 Stokes-Einstein	 equation:	 RH	 =KBT/(6πηD),	
where	KBT	is	the	system's	thermal	energy	and	η	represents	
the	 solvent	 viscosity.	 The	 electrophoretic	 mobility	
measurements	 were	 performed	 by	 means	 of	 the	 same	
apparatus	 used	 for	 size	 experiments.	 The	 mobility	 u	 of	
nanoparticles	 experiencing	 an	 external	 electric	 field	 was	
detected	and	converted	into	the	zeta-potential	by	using	the	
Smoluchowski	relation:	zeta-potential	=	uη/ε,	where	η	and	
ε	 are	 respectively	 the	 viscosity	 and	 the	permittivity	 of	 the	
solvent	 phase.	 Sample	 solutions	 of	 bare	 liposomes	 were	
diluted	1:100	with	distillated	water.	Particles	(10	mL)	were	
incubated	with	 undiluted	 HP	 (10	mL)	 for	 1	 hour	 at	 37	 °C,	
separated	 from	 plasma	 components	 by	 centrifugation,	
washed	and	 resuspended	 in	protein-free	medium	 (20	mL).	
Size	 and	 zeta-potential	 experiments	 of	 NP-HP	 complexes	
were	 carried	 out	 by	 diluting	 20	 mL	 of	 NP-HP	 complexes,	
with	980	mL	of	distillated	water.	Results	are	given	as	mean	
±	standard	deviation	of	five	replicates.		
Cell	culture	
Human	cervical	cancer	cell	 line	(HeLa)	was	purchased	from	
ATCC	 (Manassas,	 VA,	USA).	 HeLa	 cells	were	maintained	 in	
Eagle’s	Minimum	Essential	Medium	(EMEM)	supplemented	
with	2	mM	L-glutamine,	100	IU/mL	penicillin/streptomycin,	
1	 mM	 sodium	 pyruvate,	 10	 mM	 hepes,	 1.5	 mg/L	 sodium	
bicarbonate	and	10%	fetal	bovine	serum	(FBS).		
Protein	assay	
We	used	 Protein	 Assay	 reagent	 (Pierce,	 Thermo	 Scientific,	
Waltham,	 MA,	 USA)	 to	 measure	 the	 amount	 of	 bound	
proteins	 on	 liposomes	 after	 incubation	with	HP,	 according	
to	manufacturer’s	protocol.	Briefly,	after	incubation	of	each	
NP	 formulation	 with	 HP	 for	 1	 hour	 at	 37°C,	 NP-HP	
complexes	were	 centrifuged	 at	 14000	 rpm	 for	 15	minutes	
at	 4°C	 and	 washed	 3	 times	 with	 PBS.	 The	 resulting	 pellet	
was	resuspended	in	urea	8	mol/L	NH4CO3	50	mmol/.	Ten	μL	
of	each	sample	was	placed	into	a	96-multiwell	plate	adding	
then	 150	 μL	 of	 Protein	 Assay	 reagent.	 The	 multiwall	 was	
incubated	 at	 room	 temperature	 for	 5	 minutes	 and	 then	
mixed	 on	 a	 plate	 shaker.	 The	 absorbance	 of	 each	 sample,	
blank	 and	 standards	 was	 measured	 with	 the	 Glomax	
Discover	 System	 (Promega,	Madison,	WI,	USA)	 at	 660	nm.	
The	 protein	 concentration	 was	 calculated	 using	 the	
standard	 curve	 and	 all	 the	 measures	 were	 made	 in	
triplicate.	
Cell	viability	
To	 examine	 the	 possible	 cytotoxicity	 resulting	 from	 bare	
NPs,	 cell	 viability	 of	 HeLa	 cells	 was	 evaluated	 by	 using	 3-
(4,5-dymethyl	 thiazol	 2-y1)-2,5-diphenyl	 tetrazolium	
bromide	 (MTT,	 mitochondrial	 respiration	 analysis;	 Sigma-
Aldrich),	according	to	Mosmann	protocol.	Briefly,	HeLa	cells	
were	seeded	on	96-wells	plate	(10.000	cells/well).	24	hours	
after	seeding,	cells	were	treated	with	10	μg/mL	of	each	NP	
formulation	 in	 Optimem	 medium	 (Life	 Technologies,	
Carlsbad,	CA)	 for	 24	hours.	 Then,	MTT	was	 added	 to	each	
well	at	the	final	concentration	of	0.5	mg/mL.	After	4	hours	
of	incubation	at	37°C,	the	formazan	salt	was	dissolved	with	
100	μL	isopropylic	alcohol	and	the	absorbance	of	each	well	
was	 measured	 with	 Glomax	 Discover	 System	 (Promega,	
Madison,	WI,	USA)	at	570	nm.	Cell	 viability	was	calculated	
for	 each	 treatment	 as	 “OD	 of	 treated	 cells/OD	 of	 control	
cells”	 ×100.	 All	 the	 measures	 were	 made	 in	 triplicate.	
Results	are	given	as	mean	±	standard	deviation.		
Flow	cytometry	
To	determine	cellular	uptake	of	bare	NPs	in	HeLa	cells,	each	
formulation	 was	 synthesized	 with	 the	 addition	 of	 DOPE-
NBD,	with	 the	concentration	of	 fluorescently	 labeled	NBD-
DOPE	 of	 7x10-3	mg/mL	 (fluorescent	 lipid/total	 lipid	molar	
Journal	Name	 	ARTICLE	
This	journal	is	©	The	Royal	Society	of	Chemistry	20xx	 J.	Name.,	2013,	00,	1-3	|	7 	
Please	do	not	adjust	margins	
Please	do	not	adjust	margins	
ratio	=	5/1000)	(excitation	488	nm,	emission	530	nm).	HeLa	
cells	were	 seeded	 in	 12-well	 plate	 (200.000	 cells/mL)	 and,	
after	 24	 hours,	 cells	were	 treated	with	 10	 μg/mL	 of	 NBD-
labeled	 NPs	 in	 Optimem	medium	 for	 3	 hours.	 Then,	 cells	
were	 detached	 with	 trypsin/ethylenediaminetetraacetic	
acid	(EDTA),	washed	two	times	with	cold	PBS,	and	acquired	
using	 a	 cytometer.	 Fluorescence-activated	 cell	 sorting	
(FACS)	 analysis	 was	 performed	 using	 BD	 LSRFortessa	
equipped	 with	 488	 nm	 laser	 and	 with	 DIVA	 software	 (BD	
Biosciences,	San	Jose,	CA,	USA).	HeLa	cells	were	first	gated	
using	 forward	 vs	 side	 scatter	 (FSC	 vs	 SSC)	 strategy	 to	
exclude	 debris	 (low	 events)	 and	 then	 analyzed	 for	 the	
specific	 530	 nm	 emission	 (FITC	 channel).	 Data	 were	
analyzed	 using	 FlowJo	 software	 (FlowJo	 LLC	 data	 analysis	
software,	 Ashland,	 OR,	 USA).	 The	 percentage	 of	 FITC	
positive	 cells	 indicated	NP-cell	 interaction	 (Cell	 association	
%,	Table	S1	in	the	ESI).	
Cell	receptors	of	protein	corona	fingerprints	
A	 computational	 procedure,	 starting	 from	 a	 protein	
belonging	 to	 nanoparticle	 corona,	 allows	 identifying	 its	
interaction	 partners	 localized	 on	 plasma	 membrane.	 The	
procedure	approach	is	based	on	two	steps:	i)	 identification	
of	 the	 corona	 protein	 interaction	 partners	 by	 accessing	 to	
the	Mentha	 database	 of	 experimentally	 validated	 protein-
protein	 interactions43;	 then,	 ii)	 the	 list	 of	 interacting	
proteins	 is	 sorted	 according	 to	 a	 score	 calculated	 by	 a	
function	based	on	Gene	Ontology	annotations.44,	 45	Finally,	
the	 gene	 expression	 profile	 of	 proteins,	 deemed	 to	 be	
localized	 on	 plasma	 membrane,	 has	 been	 consulted	 by	
means	of	the	GENEVESTIGATOR	tool.46		
Conclusion	
A	 combinatorial	 library	 of	 16	 negatively	 or	 positively	
charged	lipid	NPs	of	various	size	and	surface	was	employed	
to	 investigate	 the	 correlation	between	NP-cell	 association,	
NP	 physicochemical	 properties	 and	 protein	 corona	
fingerprints.	 Collectively,	 our	 analyses	 demonstrate	 that	
none	of	the	NPs’	physicochemical	properties	alone	was	able	
exclusively	 to	 account	 for	 association	 with	 HeLa	 cells.	
Among	436	identified	plasma	proteins,	Vitronectin,	APOA1,	
APOA2,	 APOB,	 APOC2,	 Ig	 heavy	 chain	 V-III	 region	 BRO,	
Vitamin	K-dependent	protein,	Integrin	beta3	were	identified	
as	 being	 significant	 protein	 corona	 fingerprints	 for	
correlating	 NP	 cell	 association.	 The	 developed	 predictive	
modeling	provides	a	means	of	evaluating	 the	substance	of	
the	 identified	 corona	 proteins	 in	 promoting	 NP-cell	
association.	Identification	of	protein	corona	fingerprints	will	
be	 useful	 in	 developing	 NP	 with	 targeted	 NP	 protein	
adsorption	 and	 will	 open	 the	 intriguing	 possibility	 to	
manipulate	the	corona	composition	by	nanoparticle	design.		
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